Skip to content
Evigrade
CriticalOxazolidinone antibiotic×Reversible MAO-A inhibitor (RIMA)

Updated · Methodology

Mechanism

Linezolid is an antibiotic that reversibly and non-selectively inhibits monoamine oxidase (MAO), although it has no antidepressant effect at antibacterial doses (linezolid summary of product characteristics, SmPC, section 4.4). Moclobemide reversibly inhibits mainly MAO type A and slows the breakdown of noradrenaline, dopamine and serotonin (moclobemide SmPC, section 5.1). Both drugs act on the same enzyme, and data on linezolid in patients receiving other treatments that carry a risk of MAO inhibition are very limited (linezolid SmPC, section 4.5). The pair does not interact through liver enzymes. Cytochrome P450 (CYP) enzymes do not metabolise linezolid, and linezolid does not inhibit them, including CYP2C19 and CYP2D6, which take part in moclobemide metabolism (linezolid SmPC, section 4.5, and moclobemide SmPC, section 5.2).

Symptoms

The prescribing information does not describe how this particular combination presents: it is contraindicated in advance as a combination of two monoamine oxidase (MAO) inhibitors (linezolid and moclobemide summaries of product characteristics, SmPCs, section 4.3). With moclobemide and other drugs that raise serotonin, isolated cases of a severe combination of high temperature, confusion, overactive reflexes (hyperreflexia) and muscle jerks (myoclonus) have occurred as signs of increased serotonin activity (moclobemide SmPC, section 4.5). With linezolid and serotonergic drugs, watch for signs of serotonin syndrome: cognitive dysfunction, very high fever, hyperreflexia and poor coordination (linezolid SmPC, section 4.4). Both drugs strengthen the effect of sympathomimetics on blood pressure. Linezolid with pseudoephedrine raised systolic pressure by a mean of 30–40 mmHg, against 11–15 mmHg with linezolid alone (linezolid SmPC, section 4.5). Moclobemide may strengthen and prolong the effect of systemic sympathomimetics (moclobemide SmPC, section 4.5).

Management

The combination is contraindicated. Linezolid must not be used in patients taking drugs that inhibit monoamine oxidase (MAO) A or B, and moclobemide is named among them (linezolid summary of product characteristics, SmPC, section 4.3). Linezolid, in turn, is on the list of drugs contraindicated with moclobemide (moclobemide SmPC, sections 4.3 and 4.5). Start linezolid no earlier than two weeks after the last dose of moclobemide (linezolid SmPC, section 4.3). No document gives an interval for the opposite order, when moclobemide is started after a course of linezolid. Warn patients taking linezolid or moclobemide not to eat large amounts of tyramine-rich foods, such as aged cheese (linezolid SmPC, sections 4.4 and 4.5, and moclobemide SmPC, section 4.4). If the two drugs have nevertheless been taken together and signs of serotonin syndrome appear, the linezolid SmPC advises considering stopping one or both drugs (section 4.4). The moclobemide SmPC advises considering a lower moclobemide dose or stopping moclobemide, depending on how severe the symptoms are (section 4.4). If high temperature, confusion, hyperreflexia and myoclonus occur together, keep the patient under medical observation, in hospital if needed (moclobemide SmPC, section 4.5).

Your whole list in one report

Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email

Add more drugs

Medicine list: everything you take in one place →

Sources

Other interactions with Linezolid

Other interactions with Moclobemide